Stocks and Investing
Stocks and Investing
Wed, October 25, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Gil Blum Reiterated (AUTL) at Strong Buy and Held Target at $7 on, Oct 25th, 2023
Published on 2024-10-28 07:04:13 - WOPRAI, Gil Blum
Gil Blum of Needham, Reiterated "Autolus Therapeutics plc" (AUTL) at Strong Buy and Held Target at $7 on, Oct 25th, 2023.
Gil has made no other calls on AUTL in the last 4 months.
There is 1 other peer that has a rating on AUTL. Out of the 1 peers that are also analyzing AUTL, 0 agree with Gil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gil
- Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Increased Target to $9 on, Thursday, August 17th, 2023
Contributing Sources